Entero Healthcare Solutions Q4 FY26 results (Jan–Mar 2026) and concall

Consumer Services · Concall AI · Call held 2 Jun 2026

Company page: Entero Healthcare Solutions share price, financials & guidance record

Entero Healthcare Solutions reported strong Q4 and full year FY26 results, driven by robust organic growth, strategic acquisitions, and margin expansion. The company achieved a 4.5% EBITDA margin in Q4 and 4% for the full year, along with significant PAT growth. Management provided an optimistic FY27 guidance, targeting 23% revenue growth and 5% EBITDA margins, while focusing on operational efficiencies and MedTech expansion.

You’re reading a preview. Opening the full call uses 1 concall credit.

What they filed

Q4 FY26: revenue up 42.6%, net profit up 45.2% against the same quarter last year.

₹ Cr · quarterly

Line item	Q2 FY25	Q3 FY25	Q4 FY25	Q1 FY26	Q2 FY26	Q3 FY26	Q4 FY26
Revenue	1,301	1,359	1,339	1,404	1,571 +21%	1,707 +26%	1,910 +43%
Expenses	1,258	1,309	1,290	1,354	1,509	1,639	1,824
EBITDA	42	50	49	50	62 +48%	68 +36%	86 +76%
Margin	3%	4%	4%	4%	4%	4%	5%
Other income	11	8	7	6	5	-4	4
Interest	11	10	10	11	12	14	17
Depreciation	7	8	8	9	10	10	15
Profit before tax	35	39	37	36	45 +29%	40 +3%	58 +57%
Tax rate	25%	25%	16%	17%	18%	16%	22%
Net profit	26	29	31	30	37 +42%	34 +17%	45 +45%
EPS	5.43	5.85	5.90	6.39	7.26	6.35	6.44

How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.

What they filed

More Consumer Services earnings calls